[Skip to content]

Cancer Advice - from leading UK Cancer Specialists
Find information
In this section...
On this site...
.

Gardasil Hpv (human Papilloma Virus) vaccine prevents high grade Cin

Advances in Gynaecological cancer are very welcome and a very interesting study FUTURE II trial is coming to its end and early reports are out. This was a prospective randomised trial evaluating the incidence of HPV (16,18) related cervical intraepithelial neoplasia (CIN - the pre-cancerous condition which later leads onto cervical cancer itself)or cervical adenocarcinoma in situ (AIS) in more than 12,000 women aged between 16 and 23 randomised to receive a HPV recombinant vaccine or a placebo. Women were recruited from 90 centres in 12 countries. There are early data demonstrating a huge decrease in the incidence of the disease in the vaccinated group.